IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ponoi II Management, LLC

Q3 2021 Holdings

Filed 2021-11-12 | 4 holdings | $67.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$27.3K1,298,90840.5%
Revolution Medicines Inc(RVMD)COM76155X100$18.8K685,01127.9%
Nurix Therapeutics Inc(NRIX)COM67080M103$16.8K561,57424.9%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$4.5K145,4016.7%